iCo Therapeutics Inc $ 0.05 -0.0029 (-5.8%)
Volume:
10,000
Avg Vol (1m):
23,363
Market Cap $:
6.88 Mil
Enterprise Value $:
6.75 Mil
P/E (TTM):
0.00
P/B:
0.00
Financial Strength |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Piotroski F-Score | 3 | ||
Beneish M-Score | -13.05 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -690.07 | ||
ROA % | -156.42 | ||
ROC (Joel Greenblatt) % | -31339.29 | ||
3-Year EBITDA Growth Rate | 5.6 |
ICOTF
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
EV-to-EBIT | -5.8 | ||
EV-to-EBITDA | -5.81 | ||
Current Ratio | 0.58 | ||
Quick Ratio | 0.58 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -22.1 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Earnings Yield (Greenblatt) % | -17.25 |